|Articles|August 23, 2021
Optimizing Charge Variant and Aggregate Analysis for Biotherapeutics
Author(s)Agilent
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
3
VectorY Doses First Patient in TDP-43–Targeting ALS Trial
4
Ivonescimab Breakthrough Designation Highlights Progress in BTC Treatment
5